Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
CHI’S BIOMARKER ASSAY DEVELOPMENT
| Type | Conference |
|---|---|
| Date |
January 26, 2009
to January 28, 2009 |
| Venue |
The Westin San Diego San Diego, CA US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
CHI Representative Cambridge Healthtech Institute 250 First Ave Needham, MA 02494 US 781 972 5400 781 972 5425 chi@healthtech.com |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
The increasing importance of biomarkers in the drug discovery process calls for a comprehensive biomarker strategy that must include assay development and validation. CHI’s Inaugural Biomarker Assay Development meeting addresses “fit-for-purpose” method development, spanning pre-clinical and clinical drug development, as well as diagnostics. The meeting will provide an overview of novel assay platforms for genomic and proteomic analysis, as well as multiplexed assays, flow cytometry, and more. It will also discuss the pros and cons of developing the assay in-house vs. adopting off-the-shelf solutions/kits vs. outsourcing. And finally, since the meeting is co-located with the Translational Cancer Medicine meeting, it will also focus on biomarker assays in oncology.